Gene targeted rat resource for the study of complex disease
用于复杂疾病研究的基因靶向大鼠资源
基本信息
- 批准号:8729003
- 负责人:
- 金额:$ 184.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsCellsCollectionCommunitiesComplexCryopreservationDataDevelopmentDisastersDiseaseEnsureFibroblastsFundingGene TargetingGene-ModifiedGenesGeneticGenomicsGrantHealthHumanHuman ResourcesInvestmentsLeadLettersModelingMonoclonal Antibody R24PersonsPhenotypePhysiologicalPhysiologyPrincipal InvestigatorProcessQuantitative Trait LociRat StrainsRattusReagentRecoveryResearch InfrastructureResearch PersonnelResource DevelopmentResourcesRiskRodentSavingsScienceServicesSystemTechnologyTestingTissue BankingTissue BanksTissuesUnited States National Institutes of HealthZinc Fingersabstractingcostcost effectiveembryonic stem cellexperiencefollow-upgenome wide association studyinterestmeetingsmembernovelnucleaseoperationprogramsskillssperm celltooltrait
项目摘要
DESCRIPTION (provided by applicant):
Using the zinc finger nucleases (ZFN) technology for making gene modification or edits we generated 101 strains within two years. The ZFN technology is extraordinarily efficient and does not require the use of embryonic stem cells, as a result any rat strain should be able to be rapidly (3 to 6 months) modified.
This R24 resource grant enables our existing infrastructure: personnel, expertise in gene editing, high
throughput phenotyping, distribution channels resulting in an economies of scale that can be leverage to generate novel and important rat models to more investigators. The unique rat models already developed by our existing program, have demonstrated: 1) that the infrastructure is already in place to meet our objectives; 2) these gene modified strains can be used to validate a gene underlying a quantitative trait locus, testing a GWAS result, follow-up studies to define function of a predicted gene, or developing a model to study the physiology/mechanisms of a gene; 3) our economy of scale; 4) a full distribution system in place; and 5) over a decade of resources development (data, rats, genetic and genomic reagents) for the rat. To assure the resource meets community needs, we will establish an External Advisory Board (EAB) that will assess our progress, and conduct a scientific merit review process to select the genes and use of the resources of the R24 nominated by the scientific community (Aim 1). We plan to generate 250 gene targeted rat models (Aim 2), to provide a menu of phenotypic characterization that are available, but not required (Aim 3), and cryopreserved sperm from each line, along with a tissue and fibroblast primary culture bank for each strain, as well as distribute all the animals and reagents to the community (Aim 4).
Specific aims 1-4 are expected to generate a cost effective and powerful collection of rat models for the
community that will accelerate discovery and increase the field's understanding ofthe mechanisms involved in complex diseases. The scientific community has already nominated more than 343 genes demonstrating that the resources developed in this R24 will be of significant value to many investigators. The EAB will assure transparency and that this resource serves the community.
(End of Abstract)
描述(由申请人提供):
使用锌指核酸酶(ZFN)技术进行基因修饰或编辑,我们在两年内产生了101个菌株。 ZFN技术非常有效,不需要使用胚胎干细胞,因此,任何大鼠菌株都应该能够迅速(3至6个月)进行修改。
R24资源授予使我们现有的基础架构:人员,基因编辑专业知识,高
吞吐量表型,分配通道导致规模经济,可以将其作为为更多研究者生成新颖和重要的大鼠模型的杠杆作用。我们现有程序已经开发的独特老鼠模型已经证明:1)已经建立了基础架构来实现我们的目标; 2)这些基因修饰菌株可用于验证定量性状基因座的基因,测试GWAS结果,后续研究以定义预测基因的功能,或开发一个模型来研究基因的生理/机制; 3)规模经济; 4)完整的分配系统; 5)在十年的资源开发(数据,大鼠,遗传和基因组试剂)中,大鼠。为了确保资源满足社区需求,我们将建立一个外部顾问委员会(EAB),该委员会将评估我们的进度,并进行科学功绩审查过程,以选择科学界提名的R24资源的基因和使用(AIM 1)。我们计划生成250个基因靶向大鼠模型(AIM 2),以提供可用但不需要的表型表征菜单(AIM 3),以及每条线的冷冻保存精子,以及每种菌株的组织和成纤维细胞初级培养库,以及将所有动物和经济性分配给社区(AIM 4)。
具体目标1-4有望为大鼠模型产生成本效益和强大的鼠标收集
社区将加速发现并增加该领域对复杂疾病涉及的机制的理解。该科学界已经提名了343多个基因,证明该R24中开发的资源对许多研究人员具有重要价值。 EAB将确保透明度,并且该资源为社区服务。
(抽象的结尾)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD J JACOB其他文献
HOWARD J JACOB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD J JACOB', 18)}}的其他基金
Evaluation of human variants in disease models for end stage renal disease
终末期肾病疾病模型中人类变异的评估
- 批准号:
9116554 - 财政年份:2015
- 资助金额:
$ 184.4万 - 项目类别:
Evaluation of Human Variants in Disease Models for End Stage Renal Disease
终末期肾病疾病模型中人类变异的评估
- 批准号:
8968248 - 财政年份:2015
- 资助金额:
$ 184.4万 - 项目类别:
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease Network
未确诊疾病网络的临床全基因组测序核心
- 批准号:
9140013 - 财政年份:2015
- 资助金额:
$ 184.4万 - 项目类别:
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease Network
未确诊疾病网络的临床全基因组测序核心
- 批准号:
8774033 - 财政年份:2014
- 资助金额:
$ 184.4万 - 项目类别:
Gene targeted rat resource for the study of complex disease
用于复杂疾病研究的基因靶向大鼠资源
- 批准号:
8475961 - 财政年份:2013
- 资助金额:
$ 184.4万 - 项目类别:
Genetic and Cellular Basis of Resistance/Sensitivity to Myocardial Ischemia
对心肌缺血的抵抗/敏感性的遗传和细胞基础
- 批准号:
7740008 - 财政年份:2009
- 资助金额:
$ 184.4万 - 项目类别:
Mechanistic characterization of genes for hypertension and renal disease.
高血压和肾脏疾病基因的机制特征。
- 批准号:
7853079 - 财政年份:2009
- 资助金额:
$ 184.4万 - 项目类别:
Mechanistic characterization of genes for hypertension and renal disease.
高血压和肾脏疾病基因的机制特征。
- 批准号:
7943022 - 财政年份:2009
- 资助金额:
$ 184.4万 - 项目类别:
Genetic and Cellular Basis of Resistance/Sensitivity to Myocardial Ischemia
对心肌缺血的抵抗/敏感性的遗传和细胞基础
- 批准号:
7900535 - 财政年份:2009
- 资助金额:
$ 184.4万 - 项目类别:
Genetic and Cellular Basis of Resistance/Sensitivity to Myocardial Ischemia
对心肌缺血的抵抗/敏感性的遗传和细胞基础
- 批准号:
8118273 - 财政年份:2009
- 资助金额:
$ 184.4万 - 项目类别:
相似国自然基金
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
基于达乌尔黄鼠动物模型研究上皮细胞可塑性与异质性在前列腺季节性增生与回缩中的作用
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于达乌尔黄鼠动物模型研究上皮细胞可塑性与异质性在前列腺季节性增生与回缩中的作用
- 批准号:32270519
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 184.4万 - 项目类别:
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 184.4万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 184.4万 - 项目类别:
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 184.4万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 184.4万 - 项目类别: